Partner with the Leader in
In-Office Mammography & Tomosynthesis

Benefit from our Expertise, Innovation & Experience

Without any client capital investment or increased staffing requirement, we implement and operate preeminent screening 3D mammography (tomosynthesis) services within and for the benefit of OB/GYN practices and their patients.

Cutting Edge Service

Through decades of experience, we know that OB/GYN patients appreciate the comfort, convenience, and discretion available to them through an in-office 3D mammography service offering. We also know that 3D mammography involves many decisions beyond simply selecting a manufacturer with the best price. You must anticipate solutions for workflow, equipment, IT, staffing, maintenance, image management, interpretation, compliance and so much more.

ONsite Mammography is the preeminent developer and operator of 3D mammography services within the OB/GYN profession. We offer a comprehensive portfolio of project management, installation, and operational services that eliminate the administrative burden to providers and staff, thereby allowing them to remain focused on the delivery of quality patient care which can now include 3D mammography.

We do this without any client capital investment or increased staffing requirement.


Benefits for Providers or
Practice Administrators

ONsite Service Platform
(A Representative Listing)


  • Site Design
  • Financial Feasibility
  • IT Structure
  • EHR Integration Analysis
  • Equipment Analysis & Purchasing (No Capital Investment From Practice)


  • Project Management
  • Renovation Coordination
  • Equipment Installation And Certification
  • Registration & Licensure
  • Marketing & Patient Awareness Programs


  • Experienced Certified Imaging Technologists
  • Specialized In Breast Imaging
  • Patient-Centric Perspective
  • Employed By ONsite


  • Board-Certified Radiologists
  • Fully Credentialed & Licensed
  • Expert In Breast Imaging Interpretation
  • Will Consider Local Radiologists Meeting ONsite’s Criteria


  • State-Of-The-Art Equipment
  • Superior IT & Peripheral Technology
  • Equipment Owned, Maintained & Operated By ONsite
  • IT Infrastructure Created By ONsite


  • Entire Mammography Service Offering Operated By ONsite
  • Continuity Of Patient Care
  • Privacy & Comfort For Patients
  • Timely Reporting Of Exam Results
  • Compliance Tracking
  • ACR Guideline Briefings

Do You Qualify?

If your practice qualifies, our profitability analysis is FREE

We will provide a practice-specific financial pro forma that will allow you to assess the value proposition and opportunity offered by ONsite. We continuously update Medicare reimbursement rates and other key financial data to insure that any financial profile provided is current and accurate.

Simply submit the following information and someone from our team will contact you shortly to explain the features and direct benefits of our service platform and explore the opportunity of working together.

What's New in 3D?

Breast cancer demographics and screening guidelines

Bonnie N. Joe, MD, PhD, FSBI
University of California, San Francisco
San Francisco, California
Recent guideline updates from the American Cancer Society and the US Preventive Services Task Force (USPSTF) have unfortunately misled. . .


Tomosynthesis: What is it, and are all systems equal?

Reni S. Butler, MD
Yale University, Yale School of Medicine
New Haven, Connecticut

The technology

Digital breast tomosynthesis offers cross-sectional imaging of thin sections of the breast. Although 2-dimensional (2D) screening mammography is proven to reduce. . .

Dense breast screening: Ultrasound, tomosynthesis, or MRI?

Reni S. Butler, MD
Yale University, Yale School of Medicine
New Haven, Connecticut
Recent legislation has propelled the issue of mammographic breast density to the forefront of public attention. Currently, 24 states have breast density reporting laws, and last year a bill titled, the “Breast Density and Mammography . . .

Current best indications for breast MRI

Bruce A. Porter, MD, FACR
University of Washington, School of Medicine
Seattle, Washington
Accepted indications for magnetic resonance imaging (MRI) of the breast in high-risk breast cancer (BRCA) surveillance are evolving, variable, and often disputed. Although MRI is not indicated in women at average risk . . .

ONsite Mammography continues to innovate in a field we created.

Interpreting Radiologists

ONsite works with some of the finest Board-certified radiologists in the country. All are experienced breast image interpreters with established, impressive professional reputations. Accordingly, they are some of the most experienced interpreters of 2D mammography exams and, as it becomes more prevalent, 3D mammography studies in the United States. We are proud that one radiologist is hailed as a luminary in 3D mammography interpretation, having been a co-author of the landmark 2014 3D mammography study published in the Journal of the American Medical Association (JAMA).

We are pleased to profile one such radiologist – Debra S. Copit, M.D. – and will include more over time.

Debra S. Copit, M.D.

  • Fellowship-trained in breast imaging and in practice for over 20 years
  • Renowned expert in breast imaging and 3D mammography
  • Former Director of Breast Imaging for the Einstein Healthcare Network
  • Widely published in the field of breast health imaging
  • Co-author of study published in The Journal of the American Medical Association – June, 2014: Breast Cancer Screening Using Tomosynthesis in Combination with Digital Mammography
  • Recipient of numerous honors and awards, including UnitedHealthcare’s 2014 Educator / Researcher Of The Year
  • Philadelphia Magazine Top Doc for over 15 years in a row
  • Resides locally with family and active in the community

To contact Dr. Copit’s office, please dial: (610) 991-2565

Frequently Asked Questions

What guidelines does ONsite subscribe to regarding patient age and frequency of screening mammography?

ONsite has maintained, for years, and still maintains the position that all women 40 years of age and older should receive an annual screening mammogram. Women below the age of 40 with an increased risk of breast cancer (i.e. family history) should also receive an annual screening mammogram.

National organizations advocating the same position include:

  • American Medical Association
  • American Congress of Obstetricians & Gynecologists
  • American College of Radiology
  • Society of Breast Imaging
  • National Comprehensive Cancer Network
Is 3D mammography (tomosynthesis or digital breast tomosynthesis) reimbursed?

Effective January 1, 2015, the Centers for Medicare and Medicaid Services (CMS or Medicare) commenced reimbursement for 3D mammograms. Commercial insurance companies have been slow to respond on this topic, but we expect they will eventually reimburse for 3D as they did when the industry transitioned from analog to digital mammography.

It is important to note that several states (Illinois, Pennsylvania, and Connecticut) have enacted legislation that mandates coverage of 3D mammograms for residents of those states.

In practical terms, how is 3D mammography trending in the marketplace?

3D mammography is becoming more widely used with each passing day. Radiologists who interpret 3D mammograms on a daily basis bear witness to its clinical superiority. Women, the direct benefactors of 3D mammography, are becoming more educated about its benefits and, in an era of healthcare self-advocacy, are demanding access to this life-saving technology. ONsite and many others serving the women’s healthcare industry believe it is just a matter of time before all commercial insurance companies agree to reimburse 3D mammography. They will do so as a result of the volume of clinical evidence and/or pressure brought to bear upon them by women who simply believe they should be afforded access to the very best commercially available technology.

What is ONsite's position on 3D mammography?

We believe every woman, not just Medicare enrollees, should have access to the very best technology that will detect breast cancer at its earliest stage. All women are entitled to nothing less. Accordingly, we advocate for 3D mammography and continue our efforts to transition all of our client practices from digital mammography to 3D mammography.

How does the 3D payment portion work if our commercial carriers aren’t reimbursing yet?

When commercial carriers are not yet reimbursing, it is common for practices to collect an additional fee from each patient who received a 3D mammogram. This is typically in the range of $50-75 per patient. Based on what our various client practices tell us, patients are quite willing to pay the additional fee for the peace of mind that comes from having access to this state-of-the-art technology.

Who does the radiological interpretation?

ONsite contracts with Board-certified radiologists who specialize in breast imaging. Accordingly, they are some the most skilled and experienced interpreters of 2D mammography exams and 3D mammography studies. Each radiologist reads images from assigned client locations which they access through a secure and proprietary technology platform. A physician report for each interpreted exam is generated and transmitted back to the respective OB/GYN client for EHR filing purposes. A patient “plain-language” report (required by regulation) is also generated and mailed to each patient’s home address.

What if we’re on a hospital property?

In most situations, this is not an issue. When it has become a challenge, ONsite has worked with the client practice to achieve a favorable outcome. We encourage you to contact us to explore this topic more fully.

We don’t do mammo now so how will I find out what my reimbursements are?

You should first review your contracts with each of your carriers. We will be happy to provide you with the billing codes you would use for delivery of mammography services through your practice. Thereafter, you should determine with each carrier its 3D reimbursement total. This is, most often, a brief iterative process, and ONsite will be happy to provide guidance.

ONsite Mammography continues to innovate in a field we created.

For additional information, please contact:

Dave Freedman:
Vice President – Business Development
Telephone: (321) 424-6090

Randy Welsh:
Business Development Specialist
Telephone: (321) 424-6090

Will Bussey:
Business Development Specialist
Telephone: (321) 413-8075

Corporate Office:
ONsite Mammography • 815 North Road • Westfield, MA 01085 • Telephone: (413) 642-3759

© 2016 ONsite Mammography. All Rights Reserved